Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Consequences of isostructural main-chain modifications for the design of antimicrobial foldamers: helical mimics of host-defense peptides based on a heterogeneous amide/urea backbone.

Claudon P, Violette A, Lamour K, Decossas M, Fournel S, Heurtault B, Godet J, Mély Y, Jamart-Grégoire B, Averlant-Petit MC, Briand JP, Duportail G, Monteil H, Guichard G.

Angew Chem Int Ed Engl. 2010;49(2):333-6. doi: 10.1002/anie.200905591. No abstract available.

PMID:
19957258
2.

[Monitoring of antibiotic resistance of gram negative anaerobes].

Singer E, Calvet L, Mory F, Muller C, Chomarat M, Bézian MC, Bland S, Juvenin ME, Drugeon H, Fosse T, Goldstein F, Jaulhac B, Monteil H, Marchandin H, Jean-Pierre H, Dubreuil L.

Med Mal Infect. 2008 May;38(5):256-63. doi: 10.1016/j.medmal.2008.03.007. Epub 2008 May 14. French.

PMID:
18482812
3.

Virulence factors produced by strains of Staphylococcus aureus isolated from urinary tract infections.

Baba-Moussa L, Anani L, Scheftel JM, Couturier M, Riegel P, Haïkou N, Hounsou F, Monteil H, Sanni A, Prévost G.

J Hosp Infect. 2008 Jan;68(1):32-8. Epub 2007 Dec 11.

PMID:
18069084
4.

Distinction between pore assembly by staphylococcal alpha-toxin versus leukotoxins.

Joubert O, Voegelin J, Guillet V, Tranier S, Werner S, Colin DA, Dalla Serra M, Keller D, Monteil H, Mourey L, Prévost G.

J Biomed Biotechnol. 2007;2007(1):25935. Epub 2007 Feb 28.

5.

Site-directed mutagenesis to assess the binding capacity of class s protein of Staphylococcus aureus leucotoxins to the surface of polymorphonuclear cells.

Moussa LB, Werner S, Coraiola M, Colin DA, Keller D, Sanni A, Serra MD, Monteil H, Prévost G.

J Biomed Biotechnol. 2006;2006(2):80101.

6.

Enhanced culture of Borrelia garinii and Borrelia afzelii strains on a solid BSK-based medium in anaerobic conditions.

De Martino SJ, Sordet C, Piémont Y, Ruzic-Sabljic E, Thaddée Vetter M, Monteil H, Sibilia J, Jaulhac B.

Res Microbiol. 2006 Oct;157(8):726-9. Epub 2006 May 26.

PMID:
16814991
7.

Incidence and pathogenic effect of Streptococcus pseudopneumoniae.

Harf-Monteil C, Granello C, Le Brun C, Monteil H, Riegel P.

J Clin Microbiol. 2006 Jun;44(6):2240-1.

8.

Mimicking helical antibacterial peptides with nonpeptidic folding oligomers.

Violette A, Fournel S, Lamour K, Chaloin O, Frisch B, Briand JP, Monteil H, Guichard G.

Chem Biol. 2006 May;13(5):531-8.

9.

Detection of Chlamydia trachomatis DNA using MagNA Pure DNA extraction and Cobas Amplicor CT/NG amplification.

De Martino SJ, de Barbeyrac B, Piemont Y, Barthel C, Monteil H, Jaulhac B.

Clin Microbiol Infect. 2006 Jun;12(6):576-9.

10.

Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions.

Joubert O, Viero G, Keller D, Martinez E, Colin DA, Monteil H, Mourey L, Dalla Serra M, Prévost G.

Biochem J. 2006 Jun 1;396(2):381-9.

11.

Homologous versus heterologous interactions in the bicomponent staphylococcal gamma-haemolysin pore.

Viero G, Cunaccia R, Prévost G, Werner S, Monteil H, Keller D, Joubert O, Menestrina G, Dalla Serra M.

Biochem J. 2006 Feb 15;394(Pt 1):217-25.

12.

Multidrug-resistant Salmonella enterica serotype Senftenberg isolates producing CTX-M beta-lactamases from Constantine, Algeria.

Naas T, Lezzar A, Bentchouala C, Smati F, Scheftel JM, Monteil H, Nordmann P.

J Antimicrob Chemother. 2005 Aug;56(2):439-40. Epub 2005 Jun 20. No abstract available.

PMID:
15967765
13.
14.

[Staphylococcus resistance].

Harf-Monteil C, Prevost G, Monteil H.

Soins. 2004 Dec;(691):36-7. French. No abstract available.

PMID:
15646514
15.

Isolations of Corynebacterium kroppenstedtii from a breast abscess.

Riegel P, Liégeois P, Chenard MP, Mathelin C, Monteil H.

Int J Med Microbiol. 2004 Oct;294(6):413-6.

PMID:
15595392
16.

Peripartum bacteremias due to Leptotrichia amnionii and Sneathia sanguinegens, rare causes of fever during and after delivery.

De Martino SJ, Mahoudeau I, Brettes JP, Piemont Y, Monteil H, Jaulhac B.

J Clin Microbiol. 2004 Dec;42(12):5940-3.

17.

Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Vinion-Dubiel AD, Spilker T, Dean CR, Monteil H, LiPuma JJ, Goldberg JB.

J Clin Microbiol. 2004 Sep;42(9):4121-6.

18.

Crystal structure of leucotoxin S component: new insight into the Staphylococcal beta-barrel pore-forming toxins.

Guillet V, Roblin P, Werner S, Coraiola M, Menestrina G, Monteil H, Prévost G, Mourey L.

J Biol Chem. 2004 Sep 24;279(39):41028-37. Epub 2004 Jul 18.

19.

Determination of fosmidomycin in human serum and urine by capillary electrophoresis.

Bronner S, Renault C, Hintz M, Wiesner J, Jomaa H, Monteil H, Jehl F.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jul 5;806(2):255-61.

PMID:
15171936
20.

Regulation of virulence determinants in Staphylococcus aureus: complexity and applications.

Bronner S, Monteil H, Prévost G.

FEMS Microbiol Rev. 2004 May;28(2):183-200. Review.

21.

[Characteristics of post antibiotic Clostridium difficile and Staphylococcus aureus diarrhoea].

Kaltenbach G, Gravet A, Heitz D, Noblet-Dick M, Prévost G, Monteil H.

Presse Med. 2004 Feb 28;33(4):253. French. No abstract available.

PMID:
15029014
22.

Aeromonas simiae sp. nov., isolated from monkey faeces.

Harf-Monteil C, Flèche AL, Riegel P, Prévost G, Bermond D, Grimont PA, Monteil H.

Int J Syst Evol Microbiol. 2004 Mar;54(Pt 2):481-5.

PMID:
15023964
23.

Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia.

Lesens O, Hansmann Y, Brannigan E, Remy V, Hopkins S, Martinot M, Meyer P, Connel BO, Monteil H, Christmann D, Bergin C.

J Infect. 2004 Apr;48(3):245-52.

PMID:
15001303
24.

[Virulence factors of clinical Aeromonas caviae isolates].

Harf-Monteil C, Prévost G, Monteil H.

Pathol Biol (Paris). 2004 Feb;52(1):21-5. French.

PMID:
14761709
25.

Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus.

Menestrina G, Dalla Serra M, Comai M, Coraiola M, Viero G, Werner S, Colin DA, Monteil H, Prévost G.

FEBS Lett. 2003 Sep 18;552(1):54-60. Review.

26.

The effect of rifampin on the pharmacokinetics of vinorelbine in the micropig.

Leveque D, Wisniewski S, Renault C, Peter JD, Le Corre P, Monteil H, Jehl F.

Anticancer Res. 2003 May-Jun;23(3B):2741-4.

PMID:
12894568
27.
28.

Staphylococcal epidermolysins.

Prévost G, Couppié P, Monteil H.

Curr Opin Infect Dis. 2003 Apr;16(2):71-6. Review.

PMID:
12734438
29.

Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.

Bronner S, Jehl F, Peter JD, Ploy MC, Renault C, Arvis P, Monteil H, Prevost G.

Antimicrob Agents Chemother. 2003 May;47(5):1621-9.

30.

Isolation of sulfate-reducing bacteria from human thoracoabdominal pus.

Loubinoux J, Jaulhac B, Piemont Y, Monteil H, Le Faou AE.

J Clin Microbiol. 2003 Mar;41(3):1304-6.

31.

Ex vivo pharmacodynamics of amoxicillin-clavulanate against beta-lactamase-producing Escherichia coli in a yucatan miniature pig model that mimics human pharmacokinetics.

Bronner S, Murbach V, Peter JD, Levêque D, Elkhaïli H, Salmon Y, Dhoyen N, Monteil H, Woodnutt G, Jehl F.

Antimicrob Agents Chemother. 2002 Dec;46(12):3782-9.

32.

Dialister pneumosintes associated with human brain abscesses.

Rousée JM, Bermond D, Piémont Y, Tournoud C, Heller R, Kehrli P, Harlay ML, Monteil H, Jaulhac B.

J Clin Microbiol. 2002 Oct;40(10):3871-3.

33.

Protein engineering modulates the transport properties and ion selectivity of the pores formed by staphylococcal gamma-haemolysins in lipid membranes.

Comai M, Dalla Serra M, Coraiola M, Werner S, Colin DA, Monteil H, Prévost G, Menestrina G.

Mol Microbiol. 2002 Jun;44(5):1251-67.

34.

Bartonella bovis Bermond et al. sp. nov. and Bartonella capreoli sp. nov., isolated from European ruminants.

Bermond D, Boulouis HJ, Heller R, Van Laere G, Monteil H, Chomel BB, Sander A, Dehio C, Piémont Y.

Int J Syst Evol Microbiol. 2002 Mar;52(Pt 2):383-90.

PMID:
11931146
35.

Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent injection.

Elkhaïli H, Peter JD, Pompei D, Levless-Than-Or-Eq Slanteque D, Linger L, Salmon Y, Salmon J, Monteil H.

Clin Microbiol Infect. 1998 Jan;4(1):18-26.

37.

High-level cephalosporinase-producing Enterobacter cloacae meningitis in a newborn.

Cavalier A, Murbach V, Astruc D, Monteil H, Simeoni U, Prevost G, Messer J, Jehl F.

Clin Microbiol Infect. 1999 Jul;5(7):444-446. No abstract available.

38.

Evidence for a true post-beta-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae.

Murbach V, Dhoyen N, Linger L, Monteil H, Jehl F.

Clin Microbiol Infect. 2001 Dec;7(12):661-5.

39.

Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases.

Gravet A, Couppié P, Meunier O, Clyti E, Moreau B, Pradinaud R, Monteil H, Prévost G.

J Clin Microbiol. 2001 Dec;39(12):4349-56.

40.

[Chronic experimental bacteremia in Yucatan micropigs].

Peter JD, Murbach V, Bronner S, Levêque D, Kaltenbach G, Salmon Y, Dhoyen N, Desprez D, Hamel G, Monteil H, Jehl F.

Pathol Biol (Paris). 2001 Sep;49(7):576-82. French.

PMID:
11642022
41.

[Coze, Feltz and streptococcus].

Monteil H.

Hist Sci Med. 2000 Apr-Jun;34(2):141-6. French. No abstract available.

PMID:
11625721
42.

Ex vivo 12 h bactericidal activity of oral co-amoxiclav (1.125 g) against beta-lactamase-producing Haemophilus influenzae.

Bronner S, Pompei D, Elkhaïli H, Dhoyen N, Monteil H, Jehl F.

J Antimicrob Chemother. 2001 Oct;48(4):501-6.

PMID:
11581228
43.

Campylobacter lari bacteremia.

Martinot M, Jaulhac B, Moog R, De Martino S, Kehrli P, Monteil H, Piemont Y.

Clin Microbiol Infect. 2001 Feb;7(2):96-7. Review. No abstract available.

44.

Flow cytometric determination of Panton-Valentine leucocidin S component binding.

Gauduchon V, Werner S, Prévost G, Monteil H, Colin DA.

Infect Immun. 2001 Apr;69(4):2390-5.

45.

Treatment resistant Lyme arthritis caused by Borrelia garinii.

Limbach FX, Jaulhac B, Puechal X, Monteil H, Kuntz JL, Piemont Y, Sibilia J.

Ann Rheum Dis. 2001 Mar;60(3):284-6.

46.

Bartonella birtlesii sp. nov., isolated from small mammals (Apodemus spp.).

Bermond D, Heller R, Barrat F, Delacour G, Dehio C, Alliot A, Monteil H, Chomel B, Boulouis HJ, Piémont Y.

Int J Syst Evol Microbiol. 2000 Nov;50 Pt 6:1973-9.

PMID:
11155970
47.

Crystal structure of the F component of the Panton-Valentine leucocidin.

Pédelacq JD, Prévost G, Monteil H, Mourey L, Samama JP.

Int J Med Microbiol. 2000 Oct;290(4-5):395-401.

PMID:
11111917
48.

Variable expressions of Staphylococcus aureus bicomponent leucotoxins semiquantified by competitive reverse transcription-PCR.

Bronner S, Stoessel P, Gravet A, Monteil H, Prévost G.

Appl Environ Microbiol. 2000 Sep;66(9):3931-8.

49.

[Bacterial growth delay in E. coli: demonstration and evaluation of the beta-lactamase post-inhibitor effect on 6 strains with different resistance phenotypes].

Murbach V, Bronner S, Dhoyen N, Sougakoff W, Monteil H, Jehl F.

Pathol Biol (Paris). 2000 Jun;48(5):478-84. French.

PMID:
10949845
50.

Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis.

Jaulhac B, Heller R, Limbach FX, Hansmann Y, Lipsker D, Monteil H, Sibilia J, Piémont Y.

J Clin Microbiol. 2000 May;38(5):1895-900.

Supplemental Content

Loading ...
Support Center